X-Twitter refugee looking for a safer place. I spend most of my time working on access to medicines and intellectual property at www.medicineslawandpolicy.org. If not, I cook.
Ellen 't Hoen
Loading...
This is an interesting new @medicinespatentpool.org licence. Generic manufacturers, anywhere in the world, interested in producing baloxavir marboxil should contact the MPP through its expression of interest portal: medicinespatentpool.org/partners/how...
Met dank aan @wemos.org om mij hierbij te betrekken. Transparantie is de basis van een democratische samenleving en het vertrouwen in de instituties en bedrijven die er actief zijn. Dat geldt ook voor de farmaceutische industrie.
FT Exclusive: Four months after its establishment, the organisation’s financial fund set up by the World Bank has received no money from donors, according to four people familiar with the matter. ft.trib.al/LQLpKfw
Our blog on the state of play in the @who.int PABS negotiations. medicineslawandpolicy.org/2026/05/worl...
US pharma threaten to withhold products from Europe over prices
giftarticle.ft.com/giftarticle/...
Just out: our overview of over two decades of the use of TRIPS flexibilities to access medicines in BMJ Global Health gh.bmj.com/content/11/1...
Meanwhile: US has now left the @who.int “The U.S. flag had been removed from outside the WHO headquarters in Geneva on Thursday, according to witnesses.” www.reuters.com/business/hea...
Ellen 't Hoen
New Oxfam Inequality report just dropped:
Billionaire wealth has grown by 80% since 2020.
The world’s 12 richest billionaires have more wealth than the poorest half of humanity.
Elon Musk is the first ever person to have over half a trillion dollars wealth.
Ellen 't Hoen
📢 Maak #geengeheim van mijn medicijn.
@ellenthoen.bsky.social is expert patentrecht en directeur van @medslawpolicy.bsky.social. Zij ondertekende de open brief aan de regering en Tweede Kamer voor meer transparantie in de farma-sector.
✍ Lees en onderteken de brief op www.wemos.org/geengeheim.
Financial Times
When the @who.int Executive Board discusses agenda item 14 on the draft updated global action plan on antimicrobial resistance (perhaps tomorrow), VMAT may crop up as a point of contention. @who.int #EB158
